NCT03633890 - DaZhu Rhodiola Rosea Capsule for Coronary Artery Disease With Angina Pectoris | Biotech Hunter

Enrollment

102

Participants

Timeline

Start Date

August 31, 2018

Primary Completion Date

February 28, 2019

Study Completion Date

February 28, 2019

Conditions

Coronary Artery Disease

Interventions

DRUG

DaZhu Rhodiola Rosea Capsule

Oral administration, 4 capsules, 3 times a day, for 8 weeks

DRUG

DaZhu Rhodiola Rosea Simulation Capsule

Oral administration, 4 capsules, 3 times a day, for 8 weeks

Trial Locations (1)

Beijing Anzhen Hospital, Capital Medical University, Beijing